Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2026-01-23 @ 9:15 PM
Study NCT ID:
NCT06829459
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2025-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
Sponsor:
Organization: